What is Neuropace, Inc.'s G&A?

Neuropace, Inc. (NPCE) reported G&A of $4.84M in Q1 2026.

How has Neuropace, Inc.'s G&A changed year-over-year?

Neuropace, Inc.'s G&A increased by 19.7% year-over-year, from $4.05M to $4.84M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Neuropace, Inc. NPCE G&A

G&A at other companies

Xenon PharmaceuticalsXENE

$23.82M+25.1%

Septerna, Inc.SEPN

$10.29M+50.0%

Relmada Therapeutics, Inc.RLMD

$11.37M+81.5%

BiohavenBHVN

$26.6M-21.7%

Harmony Biosciences Holdings, Inc.HRMY

$32.51M+4.0%

Other financials

Income statement

See full

Revenue$22.1M-2.0%

Gross profit$18.0M+4.1%

Operating income-$5.6M-8.2%

Net income-$6.7M-1.5%

EPS (diluted)-$0.20+4.8%

Balance sheet

See full

Cash & equivalents$15.6M-42.4%

Total debt$70.5M-3.7%

Total equity$14.5M-40.4%

Total assets$98.9M-10.3%

Cash flow

See full

Operating cash flow-$5.9M+21.1%

CapEx$117.0K+216%

Free cash flow-$6.0M+20.0%

Valuation

See full

Market cap$557.77M+63.4%

Enterprise value$612.6M+58.1%

P/S5.6×+1.6×

Profitability

See full

Gross margin78.3%+3.5pp

Operating margin-16.8%-3.5pp

Net margin-21.7%-4.5pp

FCF margin-10.3%-3.5pp

Returns & leverage

See full

Return on equity-111.4%-13.1pp

Debt / equity4.9×+1.9×

Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuropace, Inc.'s G&A?: Neuropace, Inc. (NPCE) reported G&A of $4.84M in Q1 2026.
How has Neuropace, Inc.'s G&A changed year-over-year?: Neuropace, Inc.'s G&A increased by 19.7% year-over-year, from $4.05M to $4.84M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.